All Pages

• Government-funded research institutions

• Acadamic research institutions

• High-Throughput Antibody Production Service

• Solutions

• Integral Molecular

• Newsletter

• Publications

• Encyclopedia

• Recombinant Protein Expression Service

• Bispecific Antibody Production Service

• Fc-Silenced Antibody Expression Service

• Afucosylated Antibody Expression Service

• Recombinant Antibody Expression Service

• ProBioGen

• Rapid Novor

• Lonza

• Atlas Antibodies

• Partnerships

• Transient Antibody Production

• Scalability & Reproducibility

• Antibody reformatting and engineering

• CHO cells – first choice for antibody production

• Antibody journal

• Newsletter

• LinkedIn Journal Club

• Therapeutics development

• About Evitria

• Events

• FAQs

• Contact

• Privacy Policy

• HTML Sitemap

• Welcome to evitria

• Blog

• bYlok® bispecific pairing technology in bsAb production

• Why CHO cells remain the first choice for antibody production

• Antibody reformatting and engineering

• Scalability & Reproducibility

• LinkedIn Journal Club

• Publications

• Encyclopedia Overview

• Thank you

• Newsletter

• Poster Download: antibody development and quality control by mass spectometry

• Download bYlok® Bispecific Pairing Technology by Lonza

• Transient Antibody Expression

• Sitemap

• Data Protection

• Antibody journal

• Contact

• FAQs

• Events

• About evitria

• Therapeutics development

• ProBioGen – Selected partner

• Rapid Novor: Selected Partner

• Lonza – Selected partner

• Atlas Antibodies – Selected partner

• Testpage

• Partnerships

• Startseite

• Recombinant Protein Expression Service

• Fc-Silenced Antibody Expression Service

• Afucosylated Antibody Expression Service

• Bispecific Antibody Production Service

• Recombinant Antibody Expression Service

• LottiAnimationTest

• Privacy Policy

• Sample Page

All Posts

• Recombinant Antibodies – 7 key insights to rAbs

• Antibody-Dependent Cellular Cytotoxicity (ADCC) – Definition, Mechanism & Application

• Afucosylated recombinant antibodies

• Recombinant Antibodies – 7 key insights to rAbs

• Afucosylated recombinant antibodies

• Antibody-Dependent Cellular Cytotoxicity (ADCC) – definition, mechanism & application

• AAX Biotech and evitria to expand access to Opti-mAb® technology in early antibody development 

• HEK293 vs. CHO for HTP Expression: Impact on Glycosylation and Folding

• Transient vs. Stable Expression in High-Throughput Antibody Screening: When to Switch

• Physical Validation at Scale: How HTP Supports AI-Designed Antibody Discovery

• Fail Fast, Succeed Faster: The Role of Early Developability Assessment

• Polyclonal Antibody Production: A Comprehensive Guide

• Bispecific Antibody Formats – exploring the diverse types & formats in therapeutic development

• Monoclonal antibody production: Process, Technologies & Steps

• FDA approved bispecific antibodies

• Bispecific Antibodies: A Comprehensive Overview

• Speed vs. Quality in Early Drug Development: Striking the Right Balance for Antibody Therapeutics

• Why Promising Antibody Candidates Fail Before Clinical Trials – and How to Avoid It

• Fast-Tracking Bispecific Antibody Development: What Can Go Wrong?

• The Risks of Over-Promising in Early-Stage Biologics Development

• The Stability Problem: Why Some Recombinant Antibodies Don’t Make It to Market

• Bengt Thorsson and Johan Rockberg to join Atlas Antibodies’ Board of Directors

• Press release: evitria Celebrates 15 Years with Exclusive Giveaway for Industry Experts

• Bispecific Antibodies: A Comprehensive Overview

• Understanding the side effects of bispecific antibodies

• FDA approved bispecific antibodies

• Bispecific antibody companies: What companies are developing bispecific drug products?

• Applications of bispecific antibodies in therapeutics

• Bispecific Antibody Formats – exploring the diverse types & formats in therapeutic development

• How to choose a bispecific antibody format?

• Bispecific antibody development: Effective solutions explored

• Advantages of bispecific antibodies

• What are examples of bispecific drugs?

• What is the difference between a monoclonal and a bispecific antibody?

• HEK293 cells for recombinant antibody production

• Engineering bispecific antibodies

• Why CHO cells remain the first choice for antibody production

• Applications of mammalian cell culture in recombinant antibody production

• 7 reasons for us to choose Chinese hamster ovary (CHO) cells for recombinant protein production

• evitria and Lonza Sign License Agreement to Provide Fast Access to bYlok® Bispecific Antibodies for Discovery-Stage Transient Expression Research

• Enhanced purification services for diverse projects

• Dr. Desmond Schofield new CBO of evitria

• Therapeutic antibodies: afucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity (ADCC)

• Scalability & Reproducibility – getting it right first time, then again and again…

• Antibody reformatting and engineering – where will your variable domains take you?

• Transient antibody expression in CHO cells: Our approach at evitria

• Transient transfection vs. stable transfection

• Benefits of transient transfection

• How are afucosylated antibodies developed?

• Applications of afucosylated antibodies

• Have you recently cited evitria in your research? We say thank you – with a discount!

• What is antibody discovery?

• Antibody applications – what are antibodies used for?

• IgG Antibodies – 5 facts about Immunoglobulin G

• What is an antibody?

• Glycosylation of proteins

• Afucosylation simply explained

• Antibody characterization: What you need to know

• Antibody engineering: Opportunities & threats

• Antibody production by B cells: 7 facts

• Production of Bispecific Antibodies: 6 steps from Design to Manufacturing

• Antibody purification – 3 methods explained

• Recombinant antibody purification – methods, steps and challenges

• Recombinant antibody expression – the process in detail

• How to choose a partner for custom antibody production

• In vivo antibodies – key facts and considerations

• Steps in antibody production

• HEK cells – what’s to know on Human Embryonic Kidney Cells

• Recombinant protein production

• Bespoke solutions for lead selection and optimization in cancer antibody research

• Transient antibody production simply explained

• Antibody production in bacteria

• Antibody production in animals

• In vitro antibody production

• The Shortcut to Reliable Diagnostic, Control, and Assay Antibodies

• Monoclonal antibody production: Process, Technologies & Steps

• Success stories in recombinant antibody production

• Quality factor in recombinant antibody production

• Dr. Stefan Schmidt new CEO of evitria

• Polyclonal Antibody Production: A Comprehensive Guide

• The role of CROs in monoclonal antibody production

• CDMO antibody production: What are the services offered?

• Application of recombinant DNA technology: What is rDNA used for?

• Recombinant Protein Expression in Mammalian Cells: Techniques and Applications

• What is a CRO?

• 5 recombinant DNA examples

• What is recombinant DNA?

• Recombinant DNA – the Pros and Cons

• Monoclonal versus polyclonal antibodies

• Recombinant Antibody Production: Complete Guide

• What is an antibody sequencing service?

• What are polyclonal antibodies?

• Antibody Production simply explained

• Transient transfection – which cell lines are the best option?

• Recombinant antibody advantages and disadvantages

• Antibody production in CHO cells: Advantages & Disadvantages

• Schweizer Expertise weltweit gefragt – evitria setzt Wachstumskurs fort

• Purification of His-tagged proteins

• Monoclonal antibodies – all information

• 20,000 antibodies purified – major milestone at evitria

• Types of monoclonal antibodies

All Events

• PEGS Boston 2026

• hubXchange Antibody Therapeutics – Munich

• Antibody Engineering & Therapeutics US

• PEGS Europe 2026

• Festival of Biologics Europe

• hubXchange Antibody Manufacturing – San Francisco

• hubXchange Antibody Therapeutics – Boston

• NextGenBiomed Europe

• Keystone Symposia

• hubXchange Antibody Therapeutics

• hubXchange Antibody Therapeutics

• hubXchange Antibody Therapeutics

• hubXchange Antibody Therapeutics

• hubXchange Antibody Therapeutics

• PEGS Europe

• Festival of Biologics

• PEGS Boston

• Festival of Biologics USA

• NextGen Biomed

• hubXchange Antibody Therapeutics

• Keystone Symposia: Antibodies as Drugs: Innovative Formats, Design and Engineering

• Peptalk